Parth Mehrotra Sells 20,000 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVAGet Rating) COO Parth Mehrotra sold 20,000 shares of the business’s stock in a transaction dated Wednesday, April 20th. The stock was sold at an average price of $27.93, for a total transaction of $558,600.00. Following the completion of the sale, the chief operating officer now directly owns 97,391 shares of the company’s stock, valued at approximately $2,720,130.63. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Parth Mehrotra also recently made the following trade(s):

  • On Monday, March 28th, Parth Mehrotra sold 20,000 shares of Privia Health Group stock. The stock was sold at an average price of $25.09, for a total value of $501,800.00.
  • On Tuesday, February 22nd, Parth Mehrotra sold 20,000 shares of Privia Health Group stock. The stock was sold at an average price of $25.30, for a total value of $506,000.00.
  • On Thursday, February 10th, Parth Mehrotra sold 5,288 shares of Privia Health Group stock. The shares were sold at an average price of $25.01, for a total value of $132,252.88.

Shares of NASDAQ:PRVA traded down $1.12 during midday trading on Friday, reaching $25.07. The company had a trading volume of 16,598 shares, compared to its average volume of 720,855. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.35 and a current ratio of 2.35. Privia Health Group, Inc. has a 1-year low of $18.93 and a 1-year high of $50.77. The firm has a market cap of $2.71 billion and a price-to-earnings ratio of -13.96. The company has a fifty day simple moving average of $25.36 and a two-hundred day simple moving average of $24.63.

Privia Health Group (NASDAQ:PRVAGet Rating) last released its quarterly earnings results on Wednesday, March 23rd. The company reported ($0.11) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.13) by $0.02. Privia Health Group had a negative return on equity of 54.01% and a negative net margin of 19.48%. Analysts expect that Privia Health Group, Inc. will post 0.11 EPS for the current year.

A number of institutional investors have recently made changes to their positions in PRVA. Rockefeller Capital Management L.P. purchased a new stake in Privia Health Group in the 4th quarter worth about $25,000. First Horizon Advisors Inc. purchased a new stake in shares of Privia Health Group during the 4th quarter worth about $26,000. FourThought Financial LLC purchased a new stake in shares of Privia Health Group during the 3rd quarter worth about $32,000. Fifth Third Bancorp purchased a new stake in shares of Privia Health Group during the 4th quarter worth about $68,000. Finally, Royal Bank of Canada purchased a new stake in shares of Privia Health Group during the 2nd quarter worth about $74,000. 53.88% of the stock is owned by hedge funds and other institutional investors.

Several research firms recently issued reports on PRVA. Jefferies Financial Group began coverage on Privia Health Group in a research report on Monday, January 3rd. They set a “buy” rating and a $33.00 price target on the stock. Cowen raised Privia Health Group from a “market perform” rating to an “outperform” rating and set a $35.00 price target on the stock in a research report on Tuesday, February 22nd. Guggenheim assumed coverage on Privia Health Group in a research report on Tuesday, March 29th. They set a “buy” rating and a $35.00 price target on the stock. SVB Leerink increased their target price on Privia Health Group from $43.00 to $44.00 and gave the stock an “outperform” rating in a research report on Friday, March 25th. Finally, Canaccord Genuity Group dropped their target price on Privia Health Group from $50.00 to $44.00 and set a “buy” rating on the stock in a research report on Thursday, March 24th. One analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, Privia Health Group presently has a consensus rating of “Buy” and an average target price of $41.80.

Privia Health Group Company Profile (Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Recommended Stories

Insider Buying and Selling by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.